(Q40963564)

English

Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction

scientific article published on 7 October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

immunosuppression

1 reference

based on heuristic

inferred from title

object named as

BK polyomavirus

1 reference

based on heuristic

inferred from title

author name string

G Dieplinger

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

M J Everly

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

K P Briley

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

C E Haisch

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

P Bolin

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

A Q Maldonado

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

W T Kendrick

7

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

S A Kendrick

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

C Morgan

9

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

P I Terasaki

10

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

L M Rebellato

11

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

publication date

7 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Transplant Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

848-858

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Prospective monitoring of BK virus replication in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

The decade of polyomavirus BK-associated nephropathy: state of affairs

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN).

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Clinical course of polyoma virus nephropathy in 67 renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Aggressive immunosuppression minimization reduces graft loss following diagnosis of BK virus-associated nephropathy: a comparison of two reduction strategies

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Adverse Outcomes of Tacrolimus Withdrawal in Immune-Quiescent Kidney Transplant Recipients.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Intermediate-term graft loss after renal transplantation is associated with both donor-specific antibody and acute rejection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Incidence and impact of de novo donor-specific alloantibody in primary renal allografts

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Clinical relevance of post-transplant pharmacodynamic analysis of cyclosporine in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Lower prevalence of BK virus infection in African American renal transplant recipients: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Leflunomide efficacy and pharmacodynamics for the treatment of BK viral infection

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Molecular evaluation of BK polyomavirus nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Leflunomide therapy in kidney transplantation: ready for prime time?

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients

1 reference

https://api.crossref.org/works/10.1111%2FTID.12467

21 January 2018

Identifiers

10.1111/TID.12467

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40963564&oldid=1911263255"